Volitionrx (VNRX) Total Current Liabilities (2011 - 2025)

Volitionrx (VNRX) has 11 years of Total Current Liabilities data on file, last reported at $12.2 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 56.99% year-over-year to $12.2 million; the trailing twelve-month figure through Dec 2025 stood at $12.2 million (up 56.99% YoY), and the FY2025 full-year result was $12.2 million, up 56.99% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $12.2 million, up from $11.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $31.5 million in Q1 2024 and bottomed at $5.4 million in Q2 2021.
• The 5-year median for Total Current Liabilities is $17.0 million (2022), against an average of $15.3 million.
• The widest annual swing landed in 2022, when Total Current Liabilities jumped 221.42%; it then tumbled 73.73% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $6.5 million in 2021, then soared by 166.83% to $17.4 million in 2022, then sank by 48.56% to $8.9 million in 2023, then fell by 12.89% to $7.8 million in 2024, then soared by 56.99% to $12.2 million in 2025.
• The last three Total Current Liabilities figures came in at $12.2 million (Q4 2025), $11.4 million (Q3 2025), and $9.2 million (Q2 2025), per Business Quant data.

Peer Comparison